Table 3 |
||
| Drug classes and individual drugs most commonly associated with ADRs | ||
| Drug class | Drug (ATC) | Total number (%) |
| (n = 95) | ||
| Antibiotics | Cefalexin (J01DB01) | 1 (1.0) |
| Cefalotin (J01DB03) | 6 (6.3) | |
| Cefazolin (J01DB04) | 1 (1.0) | |
| Cefepime (J01DE01) | 3 (3.1) | |
| Ceftriaxone (J01DD04) | 4 (4.2) | |
| Imipenem (J01DH51) | 2 (2.1) | |
| Oxacillin (J01CF04) | 1 (1.0) | |
| Rifampicin (J04AB02) | 1 (1.0) | |
| Vancomycin (J01XA01) | 8 (8.4) | |
| Analgesics | Metamizole (N02BB02) | 20 (21.0) |
| Paracetamol (N02BE01) | 1 (1.0) | |
| Antipsychotics | Chlorpromazine (N05AA01) | 1 (1.0) |
| Olanzapine (N05AH03) | 1 (1.0) | |
| Risperidone (N05AX08) | 1 (1.0) | |
| Opioids | Fentanyl (N01AH02) | 1 (1.0) |
| Tramadol (N02AX02) | 11 (11.6) | |
| Benzodiazepine | Diazepam (N05BA01) | 1 (1.0) |
| Midazolam (N05CD08) | 1 (1.0) | |
| ACE inhibitors | Captopril (C09BA01) | 1 (1.0) |
| Enalapril (C09AA02) | 2 (2.1) | |
| Antiarrhythmic | Amiodarone (C01BD01) | 2 (2.1) |
| Local anaesthetic | Bupivacaine (N01BB01) | 1 (1.0) |
| Anticonvulsant | Phenytoin (N03AB02) | 6 (6.3) |
| Beta-blocker | Carvedilol (C07AG02) | 1 (1.0) |
| Antiemetic | Metoclopramide (A03FA01) | 2 (2.1) |
| H2 receptor antagonist | Ranitidine (A02BA02) | 2 (2.1) |
| Antidiuretic | Furosemide (C03CA01) | 4 (4.2) |
Lobo et al. BMC Pharmacology and Toxicology 2013 14:5 doi:10.1186/2050-6511-14-5
